These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 8510937)

  • 21. Intrinsic regulation of the interactions between the SH3 domain of p85 subunit of phosphatidylinositol-3 kinase and the protein network of BCR/ABL oncogenic tyrosine kinase.
    Ren SY; Xue F; Feng J; Skorski T
    Exp Hematol; 2005 Oct; 33(10):1222-8. PubMed ID: 16219545
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-receptor tyrosine kinases c-Abl and Arg regulate the activity of C/EBPbeta.
    Li X; Liu X; Wang G; Zhu X; Qu X; Li X; Yang Y; Peng L; Li C; Li P; Huang W; Ma Q; Cao C
    J Mol Biol; 2009 Aug; 391(4):729-43. PubMed ID: 19563810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transactivation of Abl by the Crk II adapter protein requires a PNAY sequence in the Crk C-terminal SH3 domain.
    Reichman C; Singh K; Liu Y; Singh S; Li H; Fajardo JE; Fiser A; Birge RB
    Oncogene; 2005 Dec; 24(55):8187-99. PubMed ID: 16158059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystal structure of the abl-SH3 domain complexed with a designed high-affinity peptide ligand: implications for SH3-ligand interactions.
    Pisabarro MT; Serrano L; Wilmanns M
    J Mol Biol; 1998 Aug; 281(3):513-21. PubMed ID: 9698566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and characterization of two novel SH2 domain-containing proteins from a yeast two hybrid screen with the ABL tyrosine kinase.
    Oda T; Kujovich J; Reis M; Newman B; Druker BJ
    Oncogene; 1997 Sep; 15(11):1255-62. PubMed ID: 9315092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of mutant forms of the c-src gene product containing a phenylalanine substitution for tyrosine 416.
    Ferracini R; Brugge J
    Oncogene Res; 1990; 5(3):205-19. PubMed ID: 1690870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acidic residues at the carboxyl terminus of p60c-src are required for regulation of tyrosine kinase activity and transformation.
    MacAuley A; Cooper JA
    New Biol; 1990 Sep; 2(9):828-40. PubMed ID: 1703788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benzopyranones and benzothiopyranones: a class of tyrosine protein kinase inhibitors with selectivity for the v-abl kinase.
    Geissler JF; Roesel JL; Meyer T; Trinks UP; Traxler P; Lydon NB
    Cancer Res; 1992 Aug; 52(16):4492-8. PubMed ID: 1643641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequence specificity in the recognition of the epidermal growth factor receptor by the abl Src homology 2 domain.
    Zhu G; Decker SJ; Maclean D; McNamara DJ; Singh J; Sawyer TK; Saltiel AR
    Oncogene; 1994 May; 9(5):1379-85. PubMed ID: 8152798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone marrow-transforming activity of linker insertion mutants of Abelson murine leukemia virus.
    Hevezi P; Alin K; Rees-Jones R; Goff SP
    Oncogene; 1992 Nov; 7(11):2323-8. PubMed ID: 1437154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural analysis of normal and transforming mil(raf) proteins: effect of 5'-truncation on phosphorylation in vivo or in vitro.
    Patschinsky T; Bister K
    Oncogene; 1988 Oct; 3(4):357-64. PubMed ID: 3274084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. c-Abl has high intrinsic tyrosine kinase activity that is stimulated by mutation of the Src homology 3 domain and by autophosphorylation at two distinct regulatory tyrosines.
    Brasher BB; Van Etten RA
    J Biol Chem; 2000 Nov; 275(45):35631-7. PubMed ID: 10964922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA sequence analysis of an abl-related gene in the blow fly, Calliphora erythrocephala.
    Durica DS; Robinson CE; Voelker RB
    SAAS Bull Biochem Biotechnol; 1990 Jan; 3():58-62. PubMed ID: 1367423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two families of abl-related transcripts in human haematopoietic cells differing in their homology to v-abl.
    Savin KW; Adams FC; Devereux LM; Jose DG; de Kretser TA
    Mol Biol Med; 1984 Dec; 2(6):397-409. PubMed ID: 6085879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. En bloc substitution of the Src homology region 2 domain activates the transforming potential of the c-Abl protein tyrosine kinase.
    Muller AJ; Pendergast AM; Parmar K; Havlik MH; Rosenberg N; Witte ON
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3457-61. PubMed ID: 7682703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutagenic analysis of the roles of SH2 and SH3 domains in regulation of the Abl tyrosine kinase.
    Mayer BJ; Baltimore D
    Mol Cell Biol; 1994 May; 14(5):2883-94. PubMed ID: 8164650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of murine c-abl protooncogene: effect of a point mutation on oncogenic activation.
    Shore SK; Bogart SL; Reddy EP
    Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6502-6. PubMed ID: 2168550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a protein that binds to the SH3 region of Abl and is similar to Bcr and GAP-rho.
    Cicchetti P; Mayer BJ; Thiel G; Baltimore D
    Science; 1992 Aug; 257(5071):803-6. PubMed ID: 1379745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A functional screen for regulators of the c-Abl protein tyrosine kinase.
    Moro M; Walkenhorst J; Goga A; Witte ON; Superti-Furga G
    Leukemia; 1997 Apr; 11 Suppl 3():313-5. PubMed ID: 9209375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Catalytic activity and transformation potential of v-Src require arginine 385 in the substrate binding pocket.
    Senften M; Schenker G; Sowadski JM; Ballmer-Hofer K
    Oncogene; 1995 Jan; 10(1):199-203. PubMed ID: 7529917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.